![Healthcare Unfiltered artwork](https://is2-ssl.mzstatic.com/image/thumb/Podcasts114/v4/30/3f/df/303fdf2e-c977-27d1-6d36-cf01695bcec9/mza_12891986711625233985.jpg/100x100bb.jpg)
Real-World Evidence and Value-Based Care in the Academic World
Healthcare Unfiltered
English - December 01, 2020 12:25 - 57 minutes - 105 MB - ★★★★★ - 125 ratingsScience Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Direct-To-Consumer Advertising in Healthcare: Legality and Ethics
Yousuf Zafar (@yzafar), MD, GI oncologist and associate professor of medicine, Duke University, highlights perspectives that are missing from the “general rubric” of value-based care in oncology, how real-world evidence (RWE) can help augment takeaways from clinical trial data, issues of capturing the patient voice in real-world data and electronic health records, and how the FDA is utilizing RWE for expanding drug indications. Dr. Zafar shares where he sees the intersection between RWE and value-based care existing from a payer perspective as well why he believes the COVID-19 pandemic provides “fertile ground” for the prevalence of RWE.